Showing 1071-1080 of 23044 results for "".
Rethinking Contact Lenses for Myopic Kids: Why Age 7 Isn’t Too Young
https://reachmd.com/programs/eye-on-ocular-health/rethinking-contact-lenses-for-myopic-kids-why-age-7-isnt-too-young/36282/Many eye care professionals and parents still believe children must wait until their teenage years to wear contact lenses, but as Dr. Jeffrey Walline explains, modern daily disposable lenses offer improved safety, comfort, and ease of use, making them a viable option for children as young as 7 or 8.Personalizing Care for Large Cell Neuroendocrine Carcinoma
https://reachmd.com/programs/project-oncology/personalizing-care-for-large-cell-neuroendocrine-carcinoma/36458/Treatment for large cell neuroendocrine carcinoma often mirrors small cell protocols, but emerging molecular subtypes are reshaping this approach. Learn how next-generation sequencing, biology, and patient-centered decision-making are advancing individualized therapy with Dr. Junaid Arshad, AssistanLearning About the New Definition of MASLD
https://reachmd.com/programs/gi-insights/learning-about-the-new-definition-of-masld/15976/Why is non-alcoholic fatty liver disease now called metabolic dysfunction-associated steatotic liver disease, and how is it categorized?Seizures & Epilepsy: How Cell Phone Videos Could be an Effective Tool
https://reachmd.com/programs/neurofrontiers/seizures-epilepsy-how-cell-phone-videos-could-be-an-effective-tool/14999/What role do cell phone videos have in diagnosing patients with epilepsy? And how could they help non-medically trained witnesses?Biology of Embryonic Stem Cells
https://reachmd.com/programs/clinicians-roundtable/biology-of-embryonic-stem-cells/2251/John A. Kessler MD, Davee Professor of Stem Cell Biology, Chairman, Davee Department of Neurology, Northwestern University Medical School in Chicago. Dr. Kessler is one of the world’s leaders in stem cell research to repair central and peripheral nerve damage. He joins us to talk about the biologyUnlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
https://reachmd.com/programs/project-oncology/unlocking-tumor-complexity-single-cell-rna-sequencing-in-lung-cancer/36553/Single-cell RNA sequencing is transforming our understanding of tumor heterogeneity in primary lung cancers by offering insights far beyond traditional bulk sequencing. In this program, Dr. Paola Marignani explores how advanced machine learning enables faster, more precise profiling of genetic diverDiagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
https://reachmd.com/programs/deep-breaths-updates-chest/diagnosing-and-staging-non-small-cell-lung-cancer-key-updates-and-evolving-strategies/35979/For patients with non-small cell lung cancer, staging accuracy is critical in guiding treatment decisions that can significantly affect outcomes. In this expert-led discussion, Dr. Gerard Silvestri sits down with Drs. Anne Gonzalez and Jeffrey Velotta break down what clinicians need to know, includiPatient-Centered Insights for Advanced Prostate Cancer Treatment
https://reachmd.com/programs/frontlines-prostate-cancer/patient-centered-insights-for-advanced-prostate-cancer-treatment/32211/Personalizing treatment for advanced prostate cancer patients is key to maintaining quality of life. Hear expert recommendations on creating a care plan.Could T Cells Lead to New MS Treatments?
https://reachmd.com/programs/neurofrontiers/could-t-cells-lead-to-new-ms-treatments/12953/Thanks to a recent study exploring specific T cells, we might be one step closer to discovering new treatments for patients with multiple sclerosis.Exploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
https://reachmd.com/programs/the-drug-report/exploring-the-emergency-use-authorization-for-a-monoclonal-antibody-cocktail-for-covid-19/12025/Here’s what led the FDA to issue an EUA for the coadministration of casirivimab and imdevimab to block COVID-19’s attachment and entry into cells.